OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

ALK-ABELLO A/S/  DK0061802139  /

Turquoise
2024-04-19  4:51:20 PM Chg. -0.80 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
125.30DKK -0.63% 5,853
Turnover: 731,917		 -Bid Size: - -Ask Size: - 27.7 bill.DKK - 82.63
GlobeNewswire 02-16 Annual General Meeting in ALK-Abelló A/S on 14 March 2024
GlobeNewswire 02-08 Annual report 2023: ALK delivers 9% sales growth with profits up 50%
GlobeNewswire 02-05 ALK’s 2030 CO2 reduction targets have been approved by SBTi
GlobeNewswire 01-18 ALK completes first part of phase 1 trial with peanut SLIT-tablet
GlobeNewswire 2023-11-15 Nine-month interim report (Q3) 2023
GlobeNewswire 2023-08-24 Six-month interim report (Q2) 2023
GlobeNewswire 2022-03-03 Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy ta...
GlobeNewswire 2022-02-21 Annual General Meeting in ALK-Abelló A/S on 16 March 2022
GlobeNewswire 2022-02-08 Annual report 2021: ALK delivers strong sales growth of 12% with tablet sales up 29% and EBITDA up 3...
GlobeNewswire 2021-08-11 Six-month interim report (Q2) 2021
GlobeNewswire 2021-08-09 ALK upgrades its full-year financial outlook
GlobeNewswire 2021-08-04 Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-07-30 ALK and Grandpharma team up to market the first adrenaline autoinjector in China
GlobeNewswire 2021-05-11 Otonomy Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire 2021-02-11 Otonomy Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
GlobeNewswire 2021-02-10 ALK releases 2020 annual report
GlobeNewswire 2020-11-11 Nine-month interim report (Q3) 2020
GlobeNewswire 2020-11-05 ALK updates its full-year financial outlook
GlobeNewswire 2020-08-12 Six-month interim report (Q2) 2020
GlobeNewswire 2020-08-04 Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire 2020-06-15 Otonomy Provides Update on Clinical Trials and Development Programs
GlobeNewswire 2020-05-06 Three-month interim report (Q1) 2020
GlobeNewswire 2020-02-05 ALK releases its 2019 annual report
GlobeNewswire 2019-09-13 Change of Chairman at ALK
GlobeNewswire 2019-09-02 Germany becomes first launch market for ALK’s tree SLIT-tablet